SCR-LIP-000613 · Claim · machine-readable JSON →

Thyroid disorders, particularly hypothyroidism, are frequently reported as comorbidities among people with lipedema.

General proposition consolidated from 3 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
4 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20242026Characteristics and Clinical Features of Patients with Lipedema in Saudi Arabia: A Cross-sectional Comprehensive Assessment — Alosaimi et al. (2024) · consistentClinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) · consistentClinical Signs at Diagnosis and Comorbidities in a Large Cohort of Patients with Lipedema in Spain — Simarro Blasco et al. (2025) · contextualComorbidities in lipedema: toward a systemic perspective – a narrative review — Fiengo & Sbarbati (2026) · contextual

Evidence (4)

Context (PECO)

Populationlipedema patients in Spain (n=1803)
Conditionlipedema
Exposurepresence of thyroid disorders
Outcomecomorbidity prevalence alongside inflammatory conditions
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log